» Articles » PMID: 36542121

Inhibition of Uterine Contractility by Guanine-based Purines in Non-pregnant Rats

Overview
Specialty Pharmacology
Date 2022 Dec 21
PMID 36542121
Authors
Affiliations
Soon will be listed here.
Abstract

Growing evidence pointed out that guanine-based purines are able to modulate smooth muscle contractile activity of blood vessels and gastrointestinal tract. Since, so far, possible guanine-based purine modulation of uterine musculature is unknown, the aim of the present study was to investigate in vitro, using organ bath technique, guanosine and guanine effects on spontaneous uterine contraction, and uterine contraction induced by K-depolarization and oxytocin in a non-pregnant rat. Guanosine, but not guanine, reduced the amplitude of spontaneous contraction of the uterine muscle in a dose-dependent manner. The inhibitory response was antagonized by S-(4-nitrobenzyl)-6-thioinosine (NBTI), a membrane nucleoside transporter inhibitor, but persisted in the presence of theophylline, a nonselective adenosine receptor antagonist, or propanolol, β/β adrenoreceptor antagonist or blockers of a nitrergic pathway. In addition, potassium channel blockers did not influence guanosine-induced effects. Guanosine was able to inhibit the external calcium (Ca) influx-induced contraction, but it did not affect the contraction induced by high-KCl solution, indicating that guanosine does not interact with L-type voltage-gated calcium channel. Guanosine prevented/reduced uterine contractions induced by oxytocin, even in the absence of external calcium. In conclusion, guanosine is able to reduce both spontaneous and oxytocin-induced contractions of rat myometrium, likely subsequently to its intracellular intake. The blockade of extracellular Ca influx and reduction of Ca release from the intracellular store are the mechanisms involved in the guanosine-induced tocolytic effects.

References
1.
Aguilar H, Mitchell B . Physiological pathways and molecular mechanisms regulating uterine contractility. Hum Reprod Update. 2010; 16(6):725-44. DOI: 10.1093/humupd/dmq016. View

2.
Benowitz L, Jing Y, Tabibiazar R, Jo S, Petrausch B, Stuermer C . Axon outgrowth is regulated by an intracellular purine-sensitive mechanism in retinal ganglion cells. J Biol Chem. 1998; 273(45):29626-34. DOI: 10.1074/jbc.273.45.29626. View

3.
Burnstock G . Purinergic signalling in the reproductive system in health and disease. Purinergic Signal. 2013; 10(1):157-87. PMC: 3944041. DOI: 10.1007/s11302-013-9399-7. View

4.
Chaud M, Franchi A, Rettori V, McCANN S, GIMENO M . Nitric oxide in the contractile action of bradykinin, oxytocin, and prostaglandin F2 alpha in the estrogenized rat uterus. Proc Natl Acad Sci U S A. 1997; 94(20):11049-54. PMC: 23588. DOI: 10.1073/pnas.94.20.11049. View

5.
Dabertrand F, Morel J, Sorrentino V, Mironneau J, Mironneau C, Macrez N . Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells. Cell Calcium. 2006; 40(1):11-21. DOI: 10.1016/j.ceca.2006.03.008. View